Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrot...

Descripción completa

Detalles Bibliográficos
Autores principales: Erre, Gian Luca, Mangoni, Arduino Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813434/
https://www.ncbi.nlm.nih.gov/pubmed/33505479
http://dx.doi.org/10.7573/dic.2020-12-1
_version_ 1783637846774513664
author Erre, Gian Luca
Mangoni, Arduino Aleksander
author_facet Erre, Gian Luca
Mangoni, Arduino Aleksander
author_sort Erre, Gian Luca
collection PubMed
description This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.
format Online
Article
Text
id pubmed-7813434
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioExcel Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-78134342021-01-26 Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue Erre, Gian Luca Mangoni, Arduino Aleksander Drugs Context Editorial This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs. BioExcel Publishing Ltd 2021-01-15 /pmc/articles/PMC7813434/ /pubmed/33505479 http://dx.doi.org/10.7573/dic.2020-12-1 Text en Copyright © 2021 Erre GL, Mangoni AA Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.
spellingShingle Editorial
Erre, Gian Luca
Mangoni, Arduino Aleksander
Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_full Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_fullStr Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_full_unstemmed Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_short Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
title_sort current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813434/
https://www.ncbi.nlm.nih.gov/pubmed/33505479
http://dx.doi.org/10.7573/dic.2020-12-1
work_keys_str_mv AT erregianluca currenttherapeuticstrategiesinconnectivetissuediseaserelatedinterstitiallungdiseaseintroductiontothespecialissue
AT mangoniarduinoaleksander currenttherapeuticstrategiesinconnectivetissuediseaserelatedinterstitiallungdiseaseintroductiontothespecialissue

Ejemplares similares